国产不卡福利,亚洲日韩在线视频,日韩欧美亚洲综合久久,久久天天操,国产一级二级三级毛片,黄色污片在线观看,伊人精品视频在线

首頁(yè) /科研細胞 /人源細胞系 /血液 /CEM/C1(人急性淋巴細胞白血病細胞)

CEM/C1(人急性淋巴細胞白血病細胞)

CBP60711

產(chǎn)品描述
產(chǎn)品數據庫
I. General information 
Synonyms: CEM/C1
Background: CEM/C1 is a camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM (see ATCC CCL-119). The cell line was selected and subcloned in 1991 for resistance to CPT.
Species: Homo sapiens, human
Tissue: peripheral blood
Disease: acute lymphoblastic leukemia
Gender: Caucasian,Female,4 years
Morphology: lymphoblast
Growth Mode: suspension
Doubling Time: 26 hrs
DNA Profile: Our Cell Line Authentication Service
Culture Medium:

RPMI-1640 +10%FBS

CEM/C1完全培養基,# CBP60711M
We strongly suggest to purchase the complete medium from us.

Cryopreservation medium: 90%FBS+10%DMSO
Tumor Formation: Yes, in nude mice,(The cells form serially transplantable intercranial and subcutaneous tumors.)
Comments: This cell line exhibits cross resistance to both the water soluble (topotecan) and water insoluble (9-amino-CPT and 10,11-methylenedioxy-CPT) analogs of CPT.
CEM/C1 cells are approximately 31 fold less sensitive to CPT than the parental CEM cells.   CEM/C1 cells display atypical multidrug resistance (MDR) and altered topoisomerase I catalytic activity.
Resistance to CPT is stable for up to six months.
For more information, please contact us (4008-750-250).

客服

微信

掃一掃,添加二維碼

電話(huà)

留言

藥靶模型聯(lián)系方式: 華東銷(xiāo)售經(jīng)理(上海):18240630236 華東銷(xiāo)售經(jīng)理(上海、江蘇、安徽):15715191010 華中&華西銷(xiāo)售經(jīng)理:18071545918 華中&西南銷(xiāo)售經(jīng)理:13871580511 華北銷(xiāo)售經(jīng)理:18628311252 全國銷(xiāo)售經(jīng)理:13816461235
診斷標準品聯(lián)系方式: 華東銷(xiāo)售經(jīng)理:15000320447 華北銷(xiāo)售經(jīng)理:18628311252 華中&華西銷(xiāo)售經(jīng)理:18071545918 華中&西南銷(xiāo)售經(jīng)理:13871580511 全國銷(xiāo)售經(jīng)理:13816461235

掃二維碼

立即提交